6 employees
OyaGen is a biotechnology company developing novel pharmaceutical therapies that seek to exploit RNA- and DNA-editing enzymes.
2003
$3M
from 1 investors over 1 rounds
OyaGen Inc. raised $3M on September 24, 2010
Investors: Trillium Group, LLC